dual TGF-beta 1/2 antagonists (Isarna)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual TGF-beta 1/2 antagonists (Isarna)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitorsTransforming growth factor beta receptor 2 inhibitors
TargetsTransforming growth factor beta receptor 1Transforming growth factor beta receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIsarna Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsarna Therapeutics Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A